ENTRY       D10902                      Drug
NAME        Afasevikumab (USAN/INN)
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGRSLRL SCAASGFTFD DYAMHWVRQA PGKGLEWVSG INWSSGGIGY
            ADSVKGRFTI SRDNAKNSLY LQMNSLRAED TALYYCARDI GGFGEFYWNF GLWGRGTLVT
            VSSASTKGPS VFPLAPSSKS TSGGTAALGC LVKDYFPEPV TVSWNSGALT SGVHTFPAVL
            QSSGLYSLSS VVTVPSSSLG TQTYICNVNH KPSNTKVDKR VEPKSCDKTH TCPPCPAPEL
            LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSHEDPEVK FNWYVDGVEV HNAKTKPREE
            QYNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKALPAPIEK TISKAKGQPR EPQVYTLPPS
            REEMTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK
            SRWQQGNVFS CSVMHEALHN HYTQKSLSLS PGK
            (Light chain)
            EIVLTQSPAT LSLSPGERAT LSCRASQSVR SYLAWYQQKP GQAPRLLIYD ASNRATGIPA
            RFSGSGSGTD FTLTISSLEP EDFAVYYCQQ RSNWPPATFG GGTKVEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H96, H150-H206, H226-L215, H232-H'232, H235-H'235, H267-H327, H373-H431, H'22-H'96, H'150-H'206, H'226-L'215, H'267-H'327, H'373-H'431, L23-L88, L135-L195, L'23-L'88, L'135-L'195)
  TYPE      Peptide
CLASS       Immunological agent
             DG02019  Interleukin inhibitor
EFFICACY    Anti-inflammatory, Anti-IL-17A/IL-17F antibody
  TYPE      Monoclonal antibody, bispecific antibody
TARGET      IL17A [HSA:3605] [KO:K05489]
            IL17F [HSA:112744] [KO:K05494]
  PATHWAY   hsa04060(112744+3605)  Cytokine-cytokine receptor interaction
            hsa04657(112744+3605)  IL-17 signaling pathway
            hsa04659(112744+3605)  Th17 cell differentiation
BRITE       Drug groups [BR:br08330]
             Immunological agent
              DG02019  Interleukin inhibitor
               D10902  Afasevikumab
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Interleukins
                IL17A
                 D10902  Afasevikumab (USAN/INN)
                IL17F
                 D10902  Afasevikumab (USAN/INN)
DBLINKS     CAS: 1589503-30-9
            PubChem: 342581763
///
